Last reviewed · How we verify
Apotex generic fentanyl TDS — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Apotex generic fentanyl TDS (Apotex generic fentanyl TDS) — University of Maryland, Baltimore.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Apotex generic fentanyl TDS TARGET | Apotex generic fentanyl TDS | University of Maryland, Baltimore | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Apotex generic fentanyl TDS CI watch — RSS
- Apotex generic fentanyl TDS CI watch — Atom
- Apotex generic fentanyl TDS CI watch — JSON
- Apotex generic fentanyl TDS alone — RSS
Cite this brief
Drug Landscape (2026). Apotex generic fentanyl TDS — Competitive Intelligence Brief. https://druglandscape.com/ci/apotex-generic-fentanyl-tds. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab